Graves Disease
What's New
Last Posted: Apr 12, 2022
- Prediction model of Graves' disease in general clinical practice based on complete blood count and biochemistry profile.
Yoshihara Ai et al. Endocrine journal 2022 - Recurrence of Graves' Disease: What Genetics of HLA and PTPN22 Can Tell Us.
Vejrazkova Daniela et al. Frontiers in endocrinology 2021 12761077 - Psoriasis Susceptibility 1 Candidate 1 (
Jiang Yanfei, et al. Immunological investigations 2021 7 1-10 - Inclusion of ALKBH5 as a candidate gene for the susceptibility of autoimmune thyroid disease.
Song Rong-Hua, et al. Advances in medical sciences 2021 7 (2) 351-358 - Predisposition to Graves' disease and Graves' ophthalmopathy by genetic variants of IL2RA.
Du Juan, et al. Journal of molecular medicine (Berlin, Germany) 2021 7 - Associations between CD160 polymorphisms and autoimmune thyroid disease: a case-control study.
He Weiwei, et al. BMC endocrine disorders 2021 7 (1) 148 - Programmed Cell Death-Ligand 1 (PD-L1) gene Single Nucleotide Polymorphism in Graves' Disease and Hashimoto's Thyroiditis in Korean Patients.
Yoon Jee Hee, et al. Endocrinology and metabolism (Seoul, Korea) 2021 6 - The VDR gene confers a genetic predisposition to Graves' disease and Graves' ophthalmopathy in the Southwest Chinese Han population.
Zhou Fangyu, et al. Gene 2021 5 145750 - The 4G/5G Polymorphism of Plasminogen Activator Inhibitor Type 1 is a Predictor of Moderate-to-Severe Thyroid Eye Disease.
Katko Monika, et al. Journal of inflammation research 2021 0 1883-1890 - Meta-analysis reveals significant association between FOXP3 polymorphisms and susceptibility to Graves' disease.
Tan Guiqin, et al. The Journal of international medical research 2021 4 (4) 3000605211004199
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2021
- Page last updated:May 23, 2022
- Content source: